methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate

Modify Date: 2024-01-09 17:54:40

methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure
methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate structure
Common Name methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate
CAS Number 60376-73-0 Molecular Weight 407.39800
Density 1.36g/cm3 Boiling Point 544.9ºC at 760 mmHg
Molecular Formula C17H17N3O7S Melting Point N/A
MSDS N/A Flash Point 283.3ºC

 Names

Name methyl 3-(dimethylaminomethylideneamino)sulfonyl-5-nitro-4-phenoxybenzoate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.36g/cm3
Boiling Point 544.9ºC at 760 mmHg
Molecular Formula C17H17N3O7S
Molecular Weight 407.39800
Flash Point 283.3ºC
Exact Mass 407.07900
PSA 139.47000
LogP 4.05630
Index of Refraction 1.595

 Safety Information

HS Code 2935009090

 Synthetic Route

~%

methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure

methyl 3-[[[(di...

CAS#:60376-73-0

Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2

~%

methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure

methyl 3-[[[(di...

CAS#:60376-73-0

Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2

~%

methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure

methyl 3-[[[(di...

CAS#:60376-73-0

Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2

~%

methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure

methyl 3-[[[(di...

CAS#:60376-73-0

Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 Title/Abstract Full Text Show Details NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen, P.; COLLINS, Stephen, D.; KINCAID, John; DODSON, Gary, Steven Patent: WO2013/59648 A1, 2013 ;

 Customs

HS Code 2935009090
Summary 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

 Synonyms

methyl 3-({[(dimethylamino)methylene]amino}sulfonyl)-5-nitro-4-phenoxybenzoate
3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester
3-(dimethylaminomethylenesulfamoyl)-5-nitro-4-phenoxybenzoic acid methyl ester
Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-5-nitro-4-phenoxybenzoate